RSV Vaccine Cuts Lower Respiratory Disease in Older Adults
Summary
A phase 3 trial shows that a single-dose adenovirus vector RSV vaccine reduces the risk for lower respiratory tract disease by about 73% in adults aged 60 years or older.
Description from Medscape.
Who is covering this
-
RSV Vaccine Cuts Lower Respiratory Disease in Older Adults
A phase 3 trial shows that a single-dose adenovirus vector RSV vaccine reduces the risk for lower respiratory tract disease by about 73% in adults aged 60 years or older.
Comments
Comments need JavaScript.